A reconciliation of the Company's GAAP to non-GAAP results is included in Table 3 of this press release. Net cash provided by operating activities in the first nine months of 2021 was $4.709 billion, compared to $1.387 billion in the first nine months of 2020, resulting in $4.312 billion in free cash flow(1) for the first nine months of 2021, compared to $934 million for the first nine months of 2020. The increase in free cash flow was primarily due to the Company's collection of amounts due from the U.S. government in connection with REGEN-COV sales in 2021. 2021 Financial Guidance(4) The Company's full year 2021 financial guidance consists of the following components: A reconciliation of full year 2021 GAAP to Non-GAAP financial guidance is included below: Conference Call Information Regeneron will host a conference call and simultaneous webcast to discuss its third quarter 2021 financial and operating results on Thursday, November 4, 2021, at 8:30 AM Eastern Time.